Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Am J Gastroenterol
    September 2021
  1. TRIPATHI PR, Sen Sarma M, Yachha SK, Aggarwal A, et al
    Relative Adrenal Insufficiency in Decompensated Cirrhotic Children: Does It Affect Outcome?
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00094.
    >> Share

  2. LEE HW, Park SY, Lee YR, Lee H, et al
    Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
    >> Share

  3. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
    Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-990000000-00104.
    >> Share

  4. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.
    Am J Gastroenterol. 2021 Sep 7. pii: 00000434-990000000-00088.
    >> Share

  5. BLOOM PP, Robin J, Xu M, Arvind A, et al
    Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment.
    Am J Gastroenterol. 2021;116:1950-1953.
    >> Share

  6. CASTELLANA M, Donghia R, Guerra V, Procino F, et al
    Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Am J Gastroenterol. 2021;116:1833-1841.
    >> Share

  7. THULUVATH PJ, Alukal JJ, Zhang T
    A Scoring Model to Predict In-Hospital Mortality in Patients With Budd-Chiari Syndrome.
    Am J Gastroenterol. 2021;116:1905-1912.
    >> Share

    August 2021
  8. SACK JS, Liu AF, Gray M, Roat J, et al
    Association of Terry Nails With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 27. pii: 00000434-990000000-00085.
    >> Share

  9. FU XL, Chen HL
    COVID-19 Vaccine for Chronic Gastroenterology and Hepatology Patients: A Need for Better Evidence.
    Am J Gastroenterol. 2021 Aug 17. pii: 00000434-990000000-00073.
    >> Share

    July 2021
  10. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00051.
    >> Share

  11. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
    >> Share

  12. USHIDA K, Shimizu M, Yamamoto Y, Momosaki R, et al
    Strategies to Improve Exercise Adherence in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Jul 13. pii: 00000434-990000000-00043.
    >> Share

  13. PINYOPORNPANISH K, Al-Yaman W, Butler RS, Carey W, et al
    Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00036.
    >> Share

  14. MATTOS AZ, Leao GS, Bombassaro IZ, Chiesa T, et al
    Definitions for Acute-on-Chronic Liver Failure: In Dubio Pro Reo.
    Am J Gastroenterol. 2021;116:1550.
    >> Share

    June 2021
  15. JINDAL A, Mukund A
    Management of Portal Vein Thrombosis in Cirrhosis-Need a Closer Look!
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00025.
    >> Share

  16. ZHAI LL, Tang ZG
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: Several Confounding Factors.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00016.
    >> Share

  17. ACHARYA C, Nadhem O, Shaw J, Hassouneh R, et al
    Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Am J Gastroenterol. 2021 Jun 18. pii: 00000434-990000000-00012.
    >> Share

  18. LOUISSAINT J, May FP, Williams S, Tapper EB, et al
    Effective Mentorship as a Means to Recruit, Retain, and Promote Underrepresented Minorities in Academic Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:1110-1113.
    >> Share

  19. CRAVEN LJ, Parvathy SN, Burton JP, Silverman MS, et al
    Response to Ianiro et al.
    Am J Gastroenterol. 2021;116:1361-1362.
    >> Share

  20. IANIRO G, Porcari S, Gasbarrini A, Cammarota G, et al
    Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better?
    Am J Gastroenterol. 2021;116:1360-1361.
    >> Share

  21. BENMASSAOUD A, Tsochatzis E
    Response to Debnath and Rathi.
    Am J Gastroenterol. 2021;116:1358-1359.
    >> Share

  22. DEBNATH P, Rathi P
    Sarcopenia and TIPS: How Best to Measure Muscle Mass.
    Am J Gastroenterol. 2021;116:1358.
    >> Share

  23. WU F, Pahkala K, Juonala M, Jaakkola J, et al
    Childhood and Adulthood Passive Smoking and Nonalcoholic Fatty Liver in Midlife: A 31-year Cohort Study.
    Am J Gastroenterol. 2021;116:1256-1263.
    >> Share

    May 2021
  24. HERNANDEZ-CONDE M, Llop E, Gomez-Pimpollo L, Fernandez Carrillo C, et al
    Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 May 26. pii: 00000434-900000000-98756.
    >> Share

  25. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
    Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
    >> Share

  26. JOHN BV, Khakoo NS, Schwartz KB, Aitchenson G, et al
    Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98782.
    >> Share

  27. GOET JC, Murillo Perez CF, Harms MH, Floreani A, et al
    A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98792.
    >> Share

  28. WANG R, Yang L, Hu C, Yan J, et al
    A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:1097-1098.
    >> Share

  29. BENMASSAOUD A, Tsochatzis E
    Response to Anand and Sharma.
    Am J Gastroenterol. 2021;116:1094-1095.
    >> Share

  30. BJORNSSON HK, Bjornsson ES
    Database Studies on Drug-Induced Liver Injury: The Importance of Causality Assessment.
    Am J Gastroenterol. 2021;116:1090-1091.
    >> Share

  31. CHALASANI NP, Maddur H, Russo MW, Wong RJ, et al
    ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:878-898.
    >> Share

  32. VILAR-GOMEZ E, Pirola CJ, Sookoian S, Wilson LA, et al
    Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
    Am J Gastroenterol. 2021;116:994-1006.
    >> Share

  33. YATACO ML, Bowman AW, Keaveny AP
    Management of the Incidental Liver Lesion.
    Am J Gastroenterol. 2021;116:855-861.
    >> Share

  34. ESLAM M, Wong GL, Hashem AM, Chan HL, et al
    A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
    Am J Gastroenterol. 2021;116:984-993.
    >> Share

    April 2021
  35. GROVER I, Gunjan D, Singh N, Benjamin J, et al
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98797.
    >> Share

  36. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    >> Share

  37. THORNTON C, Somayaji R, Parkins M, Swain MG, et al
    Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98795.
    >> Share

  38. MA C, Qian AS, Nguyen NH, Stukalin I, et al
    Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
    Am J Gastroenterol. 2021 Apr 28. doi: 10.14309/ajg.0000000000001292.
    >> Share

  39. KAWAGUCHI Y, Hasegawa K, Hagiwara Y, De Bellis M, et al
    Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation.
    Am J Gastroenterol. 2021 Apr 21. pii: 00000434-900000000-98811.
    >> Share

  40. SERPER M, Reddy KR, Bewtra M, Ahmad N, et al
    COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice.
    Am J Gastroenterol. 2021 Apr 19. pii: 00000434-900000000-98813.
    >> Share

  41. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    >> Share

  42. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    >> Share

  43. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2021;116:836-837.
    >> Share

  44. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2021;116:835.
    >> Share

  45. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2021;116:723-732.
    >> Share

  46. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2021;116:717-722.
    >> Share

  47. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:631.
    >> Share

  48. TAPPER EB
    Finding Common Ground With Our MASQs Off.
    Am J Gastroenterol. 2021;116:837.
    >> Share

  49. ALUKAL JJ, Thuluvath PJ
    Reply to Morton.
    Am J Gastroenterol. 2021;116:835-836.
    >> Share

  50. YAMADA G, Hagiwara Y, Kimura T, Takeuchi Y, et al
    Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
    Am J Gastroenterol. 2021;116:733-740.
    >> Share

  51. KOK B, McNeely M, Watt M, Tandon P, et al
    Exercise Only Works If You Do It! The Holy Grail of Adherence.
    Am J Gastroenterol. 2021;116:673-674.
    >> Share

    March 2021
  52. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    >> Share

  53. AYOUB F, Ouni A, Case R, Ladna M, et al
    Dissemination of Gastroenterology and Hepatology Research on Social Media Platforms Is Associated With Increased Citation Count.
    Am J Gastroenterol. 2021 Mar 22. pii: 00000434-900000000-98848.
    >> Share

  54. JANSSON-KNODELL CL, Calderon G, Weber R, Ghabril M, et al
    Small Intestine Varices in Cirrhosis at a High-Volume Liver Transplant Center: A Retrospective Database Study and Literature Review.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98858.
    >> Share

  55. CHANDEL S, Singh V
    Hyponatremia in Cirrhosis: Role of Vasopressors.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98857.
    >> Share

  56. NAM H, Lee SW, Kwon JH, Lee HL, et al
    Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Mar 10. pii: 00000434-900000000-98856.
    >> Share

  57. GIL-GOMEZ A, Ampuero J, Rojas A, Gallego-Duran R, et al
    Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98817.
    >> Share

  58. WONG RJ, Jain MK, Therapondos G, Niu B, et al
    Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
    Am J Gastroenterol. 2021 Mar 1. pii: 00000434-900000000-98873.
    >> Share

  59. BRAILLON A
    Hepatocellular Carcinoma in Women: Could Tobacco Matter More than Sex?
    Am J Gastroenterol. 2021;116:617.
    >> Share

  60. SUBRAMANIAM M, Azad N, Wasan SK, Long MT, et al
    Equal Opportunity: Women Representation on Editorial Boards and Authorship of Editorials in Gastroenterology and Hepatology Journals.
    Am J Gastroenterol. 2021;116:613-616.
    >> Share

  61. MONROSE E, Bui A, Rosenbluth E, Dickstein D, et al
    Burden of Future Liver Abnormalities in Patients With Intrahepatic Cholestasis of Pregnancy.
    Am J Gastroenterol. 2021;116:568-575.
    >> Share

  62. SHAUKAT A, Oxentenko AS
    The Time Is Now to Understand and Address Sex-Related Disparities in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:441-443.
    >> Share

  63. PHIPPS M, Wattacheril J
    Response to Braillon.
    Am J Gastroenterol. 2021;116:617-618.
    >> Share

  64. VALENTIN N, Guerrido I, Rozenshteyn F, Pinotti R, et al
    Pregnancy Outcomes After Liver Transplantation: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2021;116:491-504.
    >> Share

    February 2021
  65. BAJAJ JS
    The Three Villages of Hepatic Encephalopathy.
    Am J Gastroenterol. 2021 Feb 26. pii: 00000434-900000000-98870.
    >> Share

  66. LV Y, Bai W, Li K, Wang Z, et al
    Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Am J Gastroenterol. 2021 Feb 25. pii: 00000434-900000000-98874.
    >> Share

  67. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    >> Share

  68. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    >> Share

    January 2021
  69. SAWAS T, Dilmaghani S, Dhaliwal L, Wang KK, et al
    Risk Factor Profiles Can Distinguish Esophageal Adenocarcinoma From Barrett's Esophagus.
    Am J Gastroenterol. 2021;116:198-201.
    >> Share

  70. LEE JI, Lee HW, Lee KS, Lee HS, et al
    Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study.
    Am J Gastroenterol. 2021;116:116-124.
    >> Share

    December 2020
  71. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    >> Share

  72. YOUNOSSI ZM, Noureddin M, Bernstein D, Kwo P, et al
    Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations.
    Am J Gastroenterol. 2020 Dec 7. doi: 10.14309/ajg.0000000000001054.
    >> Share

    November 2020
  73. KIM NJ, Jacob DA, Ioannou GN, John BV, et al
    Rates and Predictors of Undergoing Different Hepatocellular Carcinoma Screening Tests in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Nov 26. doi: 10.14309/ajg.0000000000001000.
    >> Share

  74. SHARMA S, Agarwal S, Anand A
    Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Liver Disease: Whom and How to Screen?
    Am J Gastroenterol. 2020 Nov 23. doi: 10.14309/ajg.0000000000001078.
    >> Share

  75. ANAND A, Sharma S
    Sarcopenia Does Not Worsen Outcomes in Patients With Refractory Ascites Under Transjugular Intrahepatic Portosystemic Shunt Placement-Preliminary Evidence?
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000001053.
    >> Share

  76. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020;115:1911-1914.
    >> Share

  77. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020;115:1906-1910.
    >> Share

  78. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020;115:1849-1856.
    >> Share

  79. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020;115:1775-1785.
    >> Share

  80. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020;115:1733-1736.
    >> Share

    October 2020
  81. LIU W, Wang S, Guo J, Liu X, et al
    A Bolt Method of Treating the Stent Migration After Endoscopic Ultrasound-Guided Hepaticogastrostomy.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000000938.
    >> Share

  82. LEE BP, Dodge JL, Terrault NA
    Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease.
    Am J Gastroenterol. 2020 Oct 28. doi: 10.14309/ajg.0000000000001007.
    >> Share

  83. THULUVATH PJ, To C, Amjad W
    Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000999.
    >> Share

  84. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001011.
    >> Share

  85. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001010.
    >> Share

  86. ARE VS, Knapp SM, Banerjee A, Shamseddeen H, et al
    Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000000911.
    >> Share

  87. KIM JH, Kim DJ, Kwon CI
    Pseudoaneurysmal Rupture of the Hepatic Artery Caused by a Biliary Plastic Stent.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000982.
    >> Share

  88. REIG A, Norman GL, Pares A
    Surrogate Markers for Antimitochondrial Antibody Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Oct 15. doi: 10.14309/ajg.0000000000000980.
    >> Share

  89. OZDOGAN E, Doganay L, Can D, Arikan C, et al
    Disease Course and Treatment Response of Eosinophilic Gastrointestinal Diseases in Children With Liver Transplantation: Long-Term Follow-Up.
    Am J Gastroenterol. 2020 Oct 13. doi: 10.14309/ajg.0000000000000934.
    >> Share

  90. BENMASSAOUD A, Roccarina D, Arico F, Leandro G, et al
    Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
    Am J Gastroenterol. 2020 Oct 12. doi: 10.14309/ajg.0000000000000959.
    >> Share

  91. HU C, Anjur V, Saboo K, Reddy KR, et al
    Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000971.
    >> Share

  92. PILLAI A, Ahn J, Kulik L
    Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000843.
    >> Share

  93. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000994.
    >> Share

  94. KALAMBOKIS GN, Tsiakas I, Filippas-Ntekuan S, Christaki M, et al
    Empagliflozin Eliminates Refractory Ascites and Hepatic Hydrothorax in a Patient With Primary Biliary Cirrhosis.
    Am J Gastroenterol. 2020 Oct 7. doi: 10.14309/ajg.0000000000000995.
    >> Share

  95. CHEN PT, Tzeng HL, Wang HP, Liu KL, et al
    Caput Medusae Bleeding.
    Am J Gastroenterol. 2020;115:1570.
    >> Share

    September 2020
  96. AHMED O, Pillai A
    Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000931.
    >> Share

  97. GRANITO A, Muratori L, Tovoli F, Muratori P, et al
    Surrogate Markers for Antimitochondrial Antibody-Negative Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Sep 28. doi: 10.14309/ajg.0000000000000928.
    >> Share

  98. WONG RJ, Saab S, Konyn P, Sundaram V, et al
    Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000948.
    >> Share

  99. CHEDID VG, Kamath AA, M Knudsen J, Frimannsdottir K, et al
    Three-Dimensional-Printed Liver Model Helps Learners Identify Hepatic Subsegments: A Randomized-Controlled Cross-Over Trial.
    Am J Gastroenterol. 2020 Sep 24. doi: 10.14309/ajg.0000000000000958.
    >> Share

  100. CARBALLO-FOLGOSO L, Alvarez-Navascues C, Rodriguez M
    Acute Liver Failure Associated With Ulipristal Acetate: A Case Report.
    Am J Gastroenterol. 2020;115:1542-1544.
    >> Share

  101. KIM D, Vazquez-Montesino LM, Escober JA, Fernandes CT, et al
    Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.
    Am J Gastroenterol. 2020;115:1496-1504.
    >> Share

  102. ZHAO J, Blais JE, Chui CSL, Suh IH, et al
    Association Between Nonvitamin K Antagonist Oral Anticoagulants or Warfarin and Liver Injury: A Cohort Study.
    Am J Gastroenterol. 2020;115:1513-1524.
    >> Share

    August 2020
  103. WHITFIELD JB, Masson S, Liangpunsakul S, Mueller S, et al
    Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers.
    Am J Gastroenterol. 2020 Aug 31. doi: 10.14309/ajg.0000000000000833.
    >> Share

  104. CAO Z, Liu Y, Cai M, Xu Y, et al
    The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 27. doi: 10.14309/ajg.0000000000000771.
    >> Share

  105. YE L, Zhang C, Seidensticker M, Mayerle J, et al
    Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment.
    Am J Gastroenterol. 2020 Aug 26. doi: 10.14309/ajg.0000000000000800.
    >> Share

  106. LOPEZ-TOBARUELA JM, Valverde-Lopez F, Lopez de Hierro-Ruiz M, Redondo-Cerezo E, et al
    Hepatic Abscess After Biodegradable Esophageal Stent Placement: A Rare Complication.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000821.
    >> Share

  107. TAPPER EB, Zhao L, Nikirk S, Baki J, et al
    Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000762.
    >> Share

  108. ALUKAL JJ, John S, Thuluvath PJ
    Hyponatremia in Cirrhosis: An Update.
    Am J Gastroenterol. 2020 Aug 6. doi: 10.14309/ajg.0000000000000786.
    >> Share

  109. REVERTER E, Ott P
    Compensated Cirrhosis and 20 mm Hg: A Point of No Return?
    Am J Gastroenterol. 2020 Aug 5. doi: 10.14309/ajg.0000000000000770.
    >> Share

  110. ZHANG X, Tang C, Tian D, Hou X, et al
    Management of Digestive Disorders and Procedures Associated With COVID-19.
    Am J Gastroenterol. 2020;115:1153-1155.
    >> Share

  111. YOUNES R, Govaere O, Petta S, Miele L, et al
    Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2020;115:1289-1292.
    >> Share

    July 2020
  112. SAMOYLOVA ML, Kapila N, McElroy L, Suhocki P, et al
    Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 31. doi: 10.14309/ajg.0000000000000793.
    >> Share

  113. LEVY C, Bowlus CL
    Role of Antinuclear Antibodies in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jul 22. doi: 10.14309/ajg.0000000000000765.
    >> Share

  114. GAO F, Zheng KI, Fan YC, Targher G, et al
    ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis.
    Am J Gastroenterol. 2020 Jul 16. doi: 10.14309/ajg.0000000000000780.
    >> Share

  115. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2020 Jul 14. doi: 10.14309/ajg.0000000000000747.
    >> Share

  116. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020;115:1134-1136.
    >> Share

  117. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020;115:1007-1018.
    >> Share

  118. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020;115:989-1002.
    >> Share

  119. BOWER RJ, Frenette C
    Reevaluating Goals of Therapy in Primary Biliary Cholangitis: Is Good Enough Is Not Good Enough Anymore?
    Am J Gastroenterol. 2020;115:1024-1025.
    >> Share

  120. CRAVEN L, Rahman A, Nair Parvathy S, Beaton M, et al
    Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.
    Am J Gastroenterol. 2020;115:1055-1065.
    >> Share

    June 2020
  121. BAJAJ JS, Brenner DM, Cai Q, Cash BD, et al
    Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.
    Am J Gastroenterol. 2020 Jun 23. doi: 10.14309/ajg.0000000000000709.
    >> Share

  122. PARIKH ND, Singal AG, Hutton DW, Tapper EB, et al
    Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
    Am J Gastroenterol. 2020 Jun 9. doi: 10.14309/ajg.0000000000000715.
    >> Share

  123. KOSHY AN, Farouque O, Gow PJ
    Response to Singh, et al.
    Am J Gastroenterol. 2020;115:951-952.
    >> Share

  124. MANCUSO A, Amata M, Politi F, Mitra M, et al
    Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness.
    Am J Gastroenterol. 2020;115:952-953.
    >> Share

  125. SAAB S, Kim NG, Lee EW
    Practical Tips on TIPS: When and When Not to Request It.
    Am J Gastroenterol. 2020;115:797-800.
    >> Share

  126. XU L, Xie J, Chen S, Chen Y, et al
    Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study.
    Am J Gastroenterol. 2020;115:876-884.
    >> Share

    May 2020
  127. REIG A, Norman GL, Garcia M, Shums Z, et al
    Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000690.
    >> Share

  128. PHIPPS M, Livanos A, Guo A, Pomenti S, et al
    Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000643.
    >> Share

  129. JINDAL A, Bhardwaj A, Kumar G, Sarin SK, et al
    Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient >/=20 mm Hg.
    Am J Gastroenterol. 2020 May 21. doi: 10.14309/ajg.0000000000000653.
    >> Share

  130. PATIDAR KR, Shamseddeen H, Xu C, Ghabril MS, et al
    Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study.
    Am J Gastroenterol. 2020 May 5. doi: 10.14309/ajg.0000000000000670.
    >> Share

  131. VIJAYARAGHAVAN R, Jindal A, Arora V, Choudhary A, et al
    Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
    Am J Gastroenterol. 2020;115:729-737.
    >> Share

    April 2020
  132. RUBIN JN, Gilman CAL, Gasmi B, Stern WR, et al
    Hepatocellular Carcinoma Where You Least Expect It.
    Am J Gastroenterol. 2020 Apr 10. doi: 10.14309/ajg.0000000000000616.
    >> Share

  133. MOON AM, Kim HP, Barritt AS 4th, Darling J, et al
    A Quality Improvement Initiative Results in Improved Rates of Timely Postvariceal Bleeding Surveillance Endoscopy.
    Am J Gastroenterol. 2020;115:625-628.
    >> Share

  134. HAN E, Lee YH, Kim YD, Kim BK, et al
    Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
    Am J Gastroenterol. 2020;115:584-595.
    >> Share

    March 2020
  135. SALIM TI, Nestlerode LC, Lucatorto EL, Wasserman TL, et al
    Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
    Am J Gastroenterol. 2020 Mar 31. doi: 10.14309/ajg.0000000000000609.
    >> Share

  136. BAJAJ JS, Lauridsen M, Tapper EB, Duarte-Rojo A, et al
    Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus.
    Am J Gastroenterol. 2020 Mar 30. doi: 10.14309/ajg.0000000000000603.
    >> Share

  137. KAPILA N, Dorsey YC, Shah J, King L, et al
    Transjugular Intrahepatic Portosystemic Shunt for a Challenging Pregnancy.
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000602.
    >> Share

  138. LEE JK, Merchant SA, Schneider JL, Jensen CD, et al
    Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
    Am J Gastroenterol. 2020 Mar 20. doi: 10.14309/ajg.0000000000000591.
    >> Share

  139. CHAN TT, Chan WK, Wong GL, Chan AW, et al
    Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2020 Mar 9. doi: 10.14309/ajg.0000000000000588.
    >> Share

    February 2020
  140. KOK B, Whitlock R, Ferguson T, Kowalczewski J, et al
    Health-Related Quality of Life: A Rapid Predictor of Hospitalization in Patients With Cirrhosis.
    Am J Gastroenterol. 2020 Feb 20. doi: 10.14309/ajg.0000000000000545.
    >> Share

  141. PERRY LM, Pan D, Loehfelm TW, Tejaswi S, et al
    Pancreaticoportal Fistula Causing Hepatic Necrosis Treated With Pancreatic Duct Stenting.
    Am J Gastroenterol. 2020 Feb 12. doi: 10.14309/ajg.0000000000000554.
    >> Share

  142. SINGH AD, Aggarwal M, Gupta S
    Heart of the Hepatorenal Matter!
    Am J Gastroenterol. 2020 Feb 5. doi: 10.14309/ajg.0000000000000547.
    >> Share

  143. DAI C, Jiang M
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease?
    Am J Gastroenterol. 2020;115:303-304.
    >> Share

  144. MILLER ED, Abu-Sbeih H, Styskel B, Nogueras Gonzalez GM, et al
    Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors.
    Am J Gastroenterol. 2020;115:251-261.
    >> Share

    January 2020
  145. GORDON SC, Wu KH, Lindor K, Bowlus CL, et al
    Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2020 Jan 27. doi: 10.14309/ajg.0000000000000512.
    >> Share

  146. HSU YC, Nguyen MH
    Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000507.
    >> Share

  147. CHOI J, Kim GA, Han S, Lim YS, et al
    Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.
    Am J Gastroenterol. 2020 Jan 2. doi: 10.14309/ajg.0000000000000490.
    >> Share

  148. SIMONETTO DA, Singal AK, Garcia-Tsao G, Caldwell SH, et al
    ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation.
    Am J Gastroenterol. 2020;115:18-40.
    >> Share

  149. KLOMPENHOUWER AJ, Alblas M, van Rosmalen BV, Haring MPD, et al
    Response to Chen et al.
    Am J Gastroenterol. 2020;115:147-148.
    >> Share

  150. MOON AM, Yang JY, Barritt AS 4th, Bataller R, et al
    Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century.
    Am J Gastroenterol. 2020;115:79-87.
    >> Share

  151. SINGAL AK, Arora S, Wong RJ, Satapathy SK, et al
    Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States.
    Am J Gastroenterol. 2020;115:88-95.
    >> Share

  152. DANG K, Hirode G, Singal AK, Sundaram V, et al
    Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases.
    Am J Gastroenterol. 2020;115:96-104.
    >> Share

    December 2019
  153. ARSLAN F, Vahaboglu H
    Tenofovir for the Prevention of HCC in Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Dec 16. doi: 10.14309/ajg.0000000000000477.
    >> Share

  154. GORDON S, Fraysse J, Li S, Ozbay AB, et al
    Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients.
    Am J Gastroenterol. 2019 Dec 12. doi: 10.14309/ajg.0000000000000484.
    >> Share

  155. PISCAGLIA F, Benevento F, Pecorell A, Forgione A, et al
    Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear.
    Am J Gastroenterol. 2019 Dec 5. doi: 10.14309/ajg.0000000000000483.
    >> Share

    November 2019
  156. KOSHY AN, Farouque O, Cailes B, Testro A, et al
    Impaired Cardiac Reserve on Dobutamine Stress Echocardiography Predicts the Development of Hepatorenal Syndrome.
    Am J Gastroenterol. 2019 Nov 15. doi: 10.14309/ajg.0000000000000462.
    >> Share

  157. CAZZAGON N, Lemoinne S, El Mouhadi S, Trivedi PJ, et al
    The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Nov 14. doi: 10.14309/ajg.0000000000000461.
    >> Share

  158. KOWDLEY KV, Brown KE, Ahn J, Sundaram V, et al
    Correction: ACG Clinical Guideline: Hereditary Hemochromatosis.
    Am J Gastroenterol. 2019 Nov 11. doi: 10.14309/ajg.0000000000000469.
    >> Share

  159. TAPPER EB, Rahimi RS
    Low-Value Levels: Ammonia Testing Does Not Improve the Outcomes of Overt Hepatic Encephalopathy.
    Am J Gastroenterol. 2019 Nov 8. doi: 10.14309/ajg.0000000000000454.
    >> Share

  160. GALLEGOS-OROZCO JF
    The Growing Challenge of Advanced Liver Disease Due to Alcohol Use in the United States.
    Am J Gastroenterol. 2019;114:1712-1713.
    >> Share

  161. YOUNOSSI ZM, Henry L
    The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease.
    Am J Gastroenterol. 2019;114:1714-1715.
    >> Share

  162. ALLEN AM, Therneau TM, Mara KC, Larson JJ, et al
    Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study.
    Am J Gastroenterol. 2019;114:1764-1771.
    >> Share

  163. HARRIS R, Card TR, Delahooke T, Aithal GP, et al
    Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography.
    Am J Gastroenterol. 2019;114:1744-1752.
    >> Share

    October 2019
  164. LUO X, Sui J, Yang W, Sun Q, et al
    Type 2 Diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women.
    Am J Gastroenterol. 2019 Oct 30. doi: 10.14309/ajg.0000000000000450.
    >> Share


  165. Correction: 18th International Society for Hepatic Encephalopathy and Nitrogen Metabolism Meeting Abstracts.
    Am J Gastroenterol. 2019 Oct 14. doi: 10.14309/ajg.0000000000000431.
    >> Share

  166. HAJ M, Rockey DC
    Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis.
    Am J Gastroenterol. 2019 Oct 14. doi: 10.14309/ajg.0000000000000343.
    >> Share

  167. HSU YC, Wong GL, Chen CH, Peng CY, et al
    Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.
    Am J Gastroenterol. 2019 Oct 11. pii: 00000434-900000000-00005.
    >> Share

  168. CHEN HL, Song YP, Liu K
    Model to Predict Regression of Large-Size Hepatocellular Adenoma: More Information Needed.
    Am J Gastroenterol. 2019 Oct 2. doi: 10.14309/ajg.0000000000000403.
    >> Share

    September 2019
  169. GAWRIEH S, Wilson LA, Cummings OW, Clark JM, et al
    Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels.
    Am J Gastroenterol. 2019 Sep 11. doi: 10.14309/ajg.0000000000000388.
    >> Share

  170. EFE C, Tascilar K, Montano-Loza AJ, Yoshida EM, et al
    Application of Risk Scores in the Daily Management of Primary Biliary Cholangitis: Response to Corpechot and Chazouilleres.
    Am J Gastroenterol. 2019 Sep 10. doi: 10.14309/ajg.0000000000000391.
    >> Share

  171. KHANDWALA K, Ahmed A, Abid S
    Migration of Fish Bone Into the Portal Vein Resulting in Pylephlebitis and Pyogenic Liver Abscesses.
    Am J Gastroenterol. 2019;114:1414.
    >> Share

  172. XIE K, Chen CH, Tsai SP, Lu PJ, et al
    Loss of Life Expectancy by 10 Years or More From Elevated Aspartate Aminotransferase: Finding Aspartate Aminotransferase a Better Mortality Predictor for All-Cause and Liver-Related than Alanine Aminotransferase.
    Am J Gastroenterol. 2019;114:1478-1487.
    >> Share

    August 2019
  173. HENRY Z
    Readmissions for Cirrhosis Within the Healthcare Readmissions Reduction Program: A Hidden Challenge.
    Am J Gastroenterol. 2019 Aug 23. doi: 10.14309/ajg.0000000000000368.
    >> Share

  174. BAJAJ JS, Bloom PP, Chung RT, Hassanein TI, et al
    Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice.
    Am J Gastroenterol. 2019 Aug 21. doi: 10.14309/ajg.0000000000000384.
    >> Share

  175. YOUNOSSI ZM, Stepanova M, Lawitz EJ, Reddy KR, et al
    Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
    Am J Gastroenterol. 2019 Aug 20. doi: 10.14309/ajg.0000000000000375.
    >> Share

  176. ROERECKE M, Vafaei A, Hasan OSM, Chrystoja BR, et al
    Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2019 Aug 20. doi: 10.14309/ajg.0000000000000340.
    >> Share

  177. CORPECHOT C, Chazouilleres O
    A Brief Reflection on Continuous vs Binary Risk Indicators in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2019 Aug 14. doi: 10.14309/ajg.0000000000000360.
    >> Share

  178. CARRION AF, Martin P
    Renal Dysfunction in Cirrhotic Patients.
    Am J Gastroenterol. 2019 Aug 7. doi: 10.14309/ajg.0000000000000355.
    >> Share

  179. CHAK EW
    Anticoagulation of Portal Vein Thrombosis in Cirrhosis: First, Do No Harm.
    Am J Gastroenterol. 2019 Aug 2. doi: 10.14309/ajg.0000000000000351.
    >> Share

  180. OKAFOR PN, Nnadi AK, Okoli O, Huang AE, et al
    Response to Rosenblatt et al.
    Am J Gastroenterol. 2019;114:1357-1358.
    >> Share

  181. MENDEZ-SANCHEZ N, Qi X, Vitek L, Arrese M, et al
    Evaluating an Outpatient With an Elevated Bilirubin.
    Am J Gastroenterol. 2019;114:1185-1188.
    >> Share

  182. GERHARDT F, Benesic A, Tillmann HL, Rademacher S, et al
    Iberogast-Induced Acute Liver Failure-Reexposure and In Vitro Assay Support Causality.
    Am J Gastroenterol. 2019;114:1358-1359.
    >> Share

    July 2019
  183. RACHO RG, Krishna M, Canabal JM, Keaveny AP, et al
    Liver Transplantation for Acute Liver Failure Secondary to Acute Sickle Intrahepatic Cholestasis.
    Am J Gastroenterol. 2019 Jul 31. doi: 10.14309/ajg.0000000000000345.
    >> Share

  184. ZHANG Y, Luo J, Wang C, Liu J, et al
    Long-Standing Unresolved Primary Biliary Cholangitis Leading to Systemic Amyloid A Amyloidosis With Predominant Liver Involvement: A Death Case.
    Am J Gastroenterol. 2019 Jul 31. doi: 10.14309/ajg.0000000000000338.
    >> Share

  185. CIOCAN D, Voican CS, Barbu V, Corpechot C, et al
    Intrahepatic Cholestasis Owing to a Novel Heterozygous ABCG8 Mutation and SLC4A2 Polymorphism With Favorable Outcome Under Ursodeoxycholic Acid.
    Am J Gastroenterol. 2019 Jul 22. doi: 10.14309/ajg.0000000000000328.
    >> Share

  186. KOWDLEY KV, Brown KE, Ahn J, Sundaram V, et al
    ACG Clinical Guideline: Hereditary Hemochromatosis.
    Am J Gastroenterol. 2019 Jul 22. doi: 10.14309/ajg.0000000000000315.
    >> Share

  187. RAMAI D, Ofosu A, Lai JK, Reddy M, et al
    Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study.
    Am J Gastroenterol. 2019 Jul 18. doi: 10.14309/ajg.0000000000000326.
    >> Share

  188. GONSALKORALA ES, Rahim MN, Heneghan MA
    Response to Mahla et al.
    Am J Gastroenterol. 2019;114:1179.
    >> Share

  189. MAHLA RS
    Noninvasive Chronic Liver Disease Staging and Pregnancy Outcome Measures Are Not Limited to Albumin Bilirubin and Aspartate Aminotransferase to Platelet Ratio Index Scorings System.
    Am J Gastroenterol. 2019;114:1178.
    >> Share

    June 2019
  190. EFE C, Tascilar K, Henriksson I, Lytvyak E, et al
    Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2019 Jun 19. doi: 10.14309/ajg.0000000000000290.
    >> Share

  191. ROSENBLATT R, Cohen-Mekelburg S, Shen N, Tafesh Z, et al
    Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.
    Am J Gastroenterol. 2019 Jun 10. doi: 10.14309/ajg.0000000000000257.
    >> Share

  192. BAJAJ JS, O'Leary JG, Tandon P, Wong F, et al
    Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Jun 6. doi: 10.14309/ajg.0000000000000280.
    >> Share

  193. YOKODA RT, Carey EJ
    Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Jun 4. doi: 10.14309/ajg.0000000000000268.
    >> Share

  194. PETTA S, Wai-Sun Wong V, Bugianesi E, Fracanzani AL, et al
    Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2019;114:916-928.
    >> Share

  195. JUNG HS, Chang Y, Ryu S
    Response to Lai.
    Am J Gastroenterol. 2019;114:998-1000.
    >> Share

  196. DEVARBHAVI H, Choudhury AK, Sharma MK, Maiwall R, et al
    Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.
    Am J Gastroenterol. 2019;114:929-937.
    >> Share

  197. LAI SW
    Smoking and Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2019;114:998.
    >> Share

  198. BYAMBASUKH O, Zelle D, Corpeleijn E
    Physical Activity, Fatty Liver, and Glucose Metabolism Over the Life Course: The Lifelines Cohort.
    Am J Gastroenterol. 2019;114:907-915.
    >> Share

  199. VUPPALANCHI R, Weber R, Russell S, Gawrieh S, et al
    Is Fasting Necessary for Individuals With Nonalcoholic Fatty Liver Disease to Undergo Vibration-Controlled Transient Elastography?
    Am J Gastroenterol. 2019;114:995-997.
    >> Share

    May 2019
  200. PISCAGLIA F, Sansone V
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis.
    Am J Gastroenterol. 2019 May 20. doi: 10.14309/ajg.0000000000000274.
    >> Share

  201. ROSENBLATT R, Cohen-Mekelburg S
    Fragmentation in Cirrhosis: The Excluded May Reveal the Full Story.
    Am J Gastroenterol. 2019 May 7. doi: 10.14309/ajg.0000000000000250.
    >> Share

  202. SARKAR M, VanWagner LB, Terry JG, Carr JJ, et al
    Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Am J Gastroenterol. 2019;114:758-763.
    >> Share

    April 2019
  203. ALUKAL JJ, Thuluvath PJ
    Gastrointestinal Failure in Critically Ill Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Apr 5. doi: 10.14309/ajg.0000000000000226.
    >> Share

  204. DE GRACIA HAHN D, Duret A, Mann JP
    An AGTR1 Variant Worsens Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome.
    Am J Gastroenterol. 2019;114:556-559.
    >> Share

  205. GONZALEZ SA
    Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis: Benefit or Risk?
    Am J Gastroenterol. 2019;114:553-555.
    >> Share

  206. MUSSO G, Saba F, Cassader M, Paschetta E, et al
    Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation.
    Am J Gastroenterol. 2019;114:607-619.
    >> Share

  207. CHEUNG A, Figueredo C, Rinella ME
    Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients.
    Am J Gastroenterol. 2019;114:579-590.
    >> Share

  208. CHANG Y, Cho YK, Cho J, Jung HS, et al
    Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study.
    Am J Gastroenterol. 2019;114:620-629.
    >> Share

    March 2019
  209. KLOMPENHOUWER AJ, Alblas M, Vivica van Rosmalen B, Haring MPD, et al
    Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma.
    Am J Gastroenterol. 2019 Mar 27. doi: 10.14309/ajg.0000000000000182.
    >> Share

  210. SANCHEZ-MONTES C, Aguilera V, Prieto M, Garcia-Campos M, et al
    Periesophageal Lymph Node Metastasis of Prostate Adenocarcinoma From Liver Transplant Donor.
    Am J Gastroenterol. 2019;114:378.
    >> Share

  211. JUNG HS, Chang Y, Kwon MJ, Sung E, et al
    Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.
    Am J Gastroenterol. 2019;114:453-463.
    >> Share

    February 2019
  212. OGIWARA S, Furihata M, Fukami K, Yamashita A, et al
    Hepatoid Adenocarcinoma With Enteroblastic Differentiation in the Sigmoid Colon: Lessons From a Rare Case.
    Am J Gastroenterol. 2019 Feb 26. doi: 10.14309/ajg.0000000000000176.
    >> Share

  213. LABENZ C, Toenges G, Huber Y, Nagel M, et al
    Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis.
    Am J Gastroenterol. 2019 Feb 18. doi: 10.14309/ajg.0000000000000121.
    >> Share

  214. MANCUSO A
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis.
    Am J Gastroenterol. 2019 Feb 14. doi: 10.14309/ajg.0000000000000158.
    >> Share

  215. FENG J, Qi X, Guo X, Qi X, et al
    Early-Stage Hepatocellular Carcinoma: Radiofrequency Ablation or Resection?
    Am J Gastroenterol. 2019;114:359.
    >> Share

  216. KUSHNER T, Sarkar M, Tran T
    Noninvasive Tests for Prognosticating Outcomes in Patients With Chronic Liver Disease in Pregnancy: Ready for Prime Time?
    Am J Gastroenterol. 2019;114:209-211.
    >> Share

  217. GONSALKORALA ES, Cannon MD, Lim TY, Penna L, et al
    Non-Invasive Markers (ALBI and APRI) Predict Pregnancy Outcomes in Women With Chronic Liver Disease.
    Am J Gastroenterol. 2019;114:267-275.
    >> Share

    January 2019
  218. BAJAJ JS, Fagan A, White MB, Wade JB, et al
    Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.
    Am J Gastroenterol. 2019 Jan 28. doi: 10.14309/ajg.0000000000000102.
    >> Share

  219. FENG Z, Marrero JA, Khaderi S, Singal AG, et al
    Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study.
    Am J Gastroenterol. 2019 Jan 23. doi: 10.14309/ajg.0000000000000068.
    >> Share

  220. BAJAJ JS, Tandon P, O'Leary JG, Wong F, et al
    Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis.
    Am J Gastroenterol. 2019 Jan 23. doi: 10.14309/ajg.0000000000000044.
    >> Share

  221. OKAFOR PN, Nnadi AK, Okoli O, Huang AE, et al
    Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000050.
    >> Share

  222. PARIENTE A, Chazouilleres O, Causse X, Hanslik B, et al
    Baveno-VI-Guided Prediction of Esogastric Varices in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000056.
    >> Share

  223. SINGAL AK, Bataller R, Ahn J, Kamath PS, et al
    Response to Forrest et al.
    Am J Gastroenterol. 2019;114:176.
    >> Share

  224. LOTLIKAR M, Pandey V, Chauhan S, Ingle M, et al
    Orbital Hematoma: A New Complication of Esophagogastroduodenoscopy.
    Am J Gastroenterol. 2019;114:181-182.
    >> Share

  225. ASRANI SK, Hall L, Hagan M, Sharma S, et al
    Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study.
    Am J Gastroenterol. 2019;114:98-106.
    >> Share

    December 2018
  226. PETTINARI I, Vukotic R, Stefanescu H, Pecorelli A, et al
    Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Am J Gastroenterol. 2018 Dec 11. pii: 10.1038/s41395-018-0421.
    >> Share

    November 2018
  227. YOUNOSSI ZM, Bernstein D, Shiffman ML, Kwo P, et al
    Diagnosis and Management of Primary Biliary Cholangitis.
    Am J Gastroenterol. 2018 Nov 14. pii: 10.1038/s41395-018-0390.
    >> Share

    October 2018
  228. WIELAND A, Kohli R
    Non-Alcoholic Steatohepatitis as a Growing Indication for Liver Transplantation: The Evolving Gender and Ethnic Trends.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0373.
    >> Share

  229. ASKGAARD G, Kjaer MS, Tolstrup JS
    Opportunities to Prevent Alcoholic Liver Cirrhosis in High-risk Populations: A Systematic Review With Meta-analysis.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0282.
    >> Share

  230. ESTEVEZ J, Yang JD, Leong J, Nguyen P, et al
    Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular Carcinoma.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0261.
    >> Share

  231. SHAH T, Tapper EB
    ERCP in Patients With Cirrhosis: "Risky Business" Or "Just Do It"?
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0271.
    >> Share

  232. YIP TC, Chan HL, Tse YK, Lam KL, et al
    On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0247.
    >> Share

  233. MOCTEZUMA-VELAZQUEZ C, Saffioti F, Tasayco-Huaman S, Casu S, et al
    Non-invasive Prediction of High-risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0265.
    >> Share

  234. AGARWAL PD, Lucey MR
    Genetic Variations Linked to Hepatocellular Carcinoma: Personalized Medicine Takes a Step Forward.
    Am J Gastroenterol. 2018 Oct 5. pii: 10.1038/s41395-018-0260.
    >> Share

    September 2018
  235. NEY M, Tangri N, Dobbs B, Bajaj J, et al
    Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Sep 28. pii: 10.1038/s41395-018-0243.
    >> Share

  236. LEAL C, Prado V, Colan J, Chavez-Rivera K, et al
    Adverse Events and Acute Chronic Liver Failure in Patients With Cirrhosis Undergoing Endoscopic Retrograde Cholangiopancreatography: A Multicenter Matched-Cohort Study.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0218.
    >> Share

  237. PETRICK JL, Thistle JE, Zeleniuch-Jacquotte A, Zhang X, et al
    Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0207.
    >> Share

    August 2018
  238. CARRION AF, Martin P
    When to Refer for Liver Transplantation.
    Am J Gastroenterol. 2018 Aug 31. pii: 10.1038/s41395-018-0242.
    >> Share

    July 2018
  239. ACHARYA C, Bajaj JS
    Current Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2018 Jul 13. pii: 10.1038/s41395-018-0179.
    >> Share

  240. ADEBAYO D, Neong SF, Wong F
    Refractory Ascites in Liver Cirrhosis.
    Am J Gastroenterol. 2018 Jul 5. pii: 10.1038/s41395-018-0185.
    >> Share

    June 2018
  241. VIOLI F, Talerico G, Basili S
    A Closer Look at Platelet Count and Prediction of Bleeding in Cirrhotic Patients.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0191.
    >> Share

  242. HUSSEN N, Zhu L, Tetangco E, Ellison S, et al
    Hepatoptosis in a Patient with Alcoholic Hepatitis.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0182.
    >> Share

  243. GIANNINI EG, Bodini G, Furnari M, Marabotto E, et al
    A Closer Look at Factors Associated With Bleeding in Cirrhotic Patients.
    Am J Gastroenterol. 2018 Jun 18. pii: 10.1038/s41395-018-0128.
    >> Share

  244. GIANNINI EG, Moscatelli A, Pellegatta G, Vitale A, et al
    Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.
    Am J Gastroenterol. 2018 Jun 18. pii: 10.1038/s41395-018-0131.
    >> Share

  245. LEE EW, Saab S, Kaldas F, Fletcher S, et al
    Coil-Assisted Retrograde Transvenous Obliteration (CARTO): An Alternative Treatment Option for Refractory Hepatic Encephalopathy.
    Am J Gastroenterol. 2018 Jun 14. pii: 10.1038/s41395-018-0109.
    >> Share

  246. HUANG R, Wang J, Xia J, Zhang Z, et al
    Platelet Count and Prediction of Bleeding in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0152.
    >> Share

  247. STICKEL F, Buch S, Nischalke HD, Weiss KH, et al
    Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0118.
    >> Share

  248. BAJAJ JS, Tandon P, O'Leary JG, Biggins SW, et al
    The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0119.
    >> Share

  249. SHIN JW, Jung SW, Lee SB, Lee BU, et al
    Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0093.
    >> Share

  250. MOURAD FH, Leong RW
    Gas In The Hepatic Portal Venous System Associated With Ischemic Colitis.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0110.
    >> Share

  251. MITSIALIS V, Lee LS
    Metastasis of Hepatocellular Carcinoma to Distal Colon Associated With Inferior Mesenteric Arteriovenous Fistula and Tumor Thrombus: a Case Report.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0101.
    >> Share

  252. BAJAJ JS, Acharya C, Fagan A, White MB, et al
    Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
    Am J Gastroenterol. 2018 Jun 6. pii: 10.1038/s41395-018-0085.
    >> Share

  253. LAI JC, Tandon P
    How I Approach It: Improving Nutritional Status in Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Jun 5. pii: 10.1038/s41395-018-0080.
    >> Share

    May 2018
  254. CHASCSA DM, Vargas HE
    The gastroenterologist's guide to management of the post-liver transplant patient.
    Am J Gastroenterol. 2018 May 11. pii: 10.1038/s41395-018-0049.
    >> Share

  255. HERNAEZ R, El-Serag HB
    How we approach it: treatment options for hepatocellular carcinoma.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0008.
    >> Share

    April 2018
  256. LENCI I, Milana M, Toti L, Palmieri G, et al
    An unusual duodenal polyp causing anemia in a liver-transplanted patient.
    Am J Gastroenterol. 2018 Apr 24. pii: 10.1038/s41395-018-0046.
    >> Share

  257. GINER R
    Spanish Women Hepatologists: Breaking The Glass Ceiling?
    Am J Gastroenterol. 2018;113:622-623.
    >> Share

  258. BRUMBLE L, Keaveny AP
    Editorial: The Risky Business of Fungal Infections in Patients with Cirrhosis.
    Am J Gastroenterol. 2018;113:564-566.
    >> Share

    March 2018
  259. NEIJENHUIS M, Gevers TJG, Atwell TD, Gunneson TJ, et al
    Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.
    Am J Gastroenterol. 2018 Mar 20. pii: ajg201818. doi: 10.1038/ajg.2018.
    >> Share

  260. MENDEZ-SANCHEZ N, Chavez-Tapia NC, Almeda-Valdes P, Uribe M, et al
    The management of incidental fatty liver found on imaging. What do we need to do?
    Am J Gastroenterol. 2018 Mar 16. pii: 10.1038/s41395-018-0047.
    >> Share

  261. STICKEL F, Buch S, Nischalke HD, Weiss KH, et al
    Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
    Am J Gastroenterol. 2018 Mar 13. pii: 10.1038/s41395-018-0041.
    >> Share

  262. TAPPER EB, Parikh ND, Waljee AK, Volk M, et al
    Diagnosis of Minimal Hepatic Encephalopathy: A Systematic Review of Point-of-Care Diagnostic Tests.
    Am J Gastroenterol. 2018 Mar 13. pii: ajg20186. doi: 10.1038/ajg.2018.
    >> Share

  263. THOMSON MJ, Tapper EB, Lok ASF
    Dos and Don'ts in the Management of Cirrhosis: A View from the 21st Century.
    Am J Gastroenterol. 2018 Mar 9. pii: 10.1038/s41395-018-0028.
    >> Share

    February 2018
  264. VENKATESH SK, Talwalkar JA
    When and how to use magnetic resonance elastography for patients with liver disease in clinical practice.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0012.
    >> Share

    January 2018
  265. LAINE L, Laursen SB, Zakko L, Dalton HR, et al
    Severity and Outcomes of Upper Gastrointestinal Bleeding With Bloody Vs. Coffee-Grounds Hematemesis.
    Am J Gastroenterol. 2018 Jan 30. pii: ajg20185. doi: 10.1038/ajg.2018.
    >> Share

    December 2017
  266. HUANG YW, Lee CL, Yang SS, Fu SC, et al
    Corrigendum: Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Am J Gastroenterol. 2017 Dec 26. pii: ajg2017494. doi: 10.1038/ajg.2017.
    >> Share

  267. BASILI S, Raparelli V, Napoleone L, Talerico G, et al
    Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.
    Am J Gastroenterol. 2017 Dec 19. pii: ajg2017457. doi: 10.1038/ajg.2017.
    >> Share

  268. LAI JC, Covinsky KE, McCulloch CE, Feng S, et al
    The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis.
    Am J Gastroenterol. 2017 Dec 12. pii: ajg2017443. doi: 10.1038/ajg.2017.
    >> Share

  269. HARMS MH, Lammers WJ, Thorburn D, Corpechot C, et al
    Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
    Am J Gastroenterol. 2017 Dec 12. pii: ajg2017440. doi: 10.1038/ajg.2017.
    >> Share

  270. BUNCHORNTAVAKUL C, Reddy KR
    HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017435. doi: 10.1038/ajg.2017.
    >> Share

  271. VARKARIS A, Lewis DW, Nugent FW
    Preserved Liver Transplant After PD-1 Pathway Inhibitor for Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017;112:1895-1896.
    >> Share

  272. LIU K, Wong VW, Lau K, Liu SD, et al
    Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.
    Am J Gastroenterol. 2017;112:1812-1823.
    >> Share

  273. BARATTA F, Pastori D, Polimeni L, Bucci T, et al
    Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.
    Am J Gastroenterol. 2017;112:1832-1839.
    >> Share

    October 2017
  274. SINGAL AG
    CON: Hepatocellular Carcinoma Surveillance: In Need of Higher-Quality Data.
    Am J Gastroenterol. 2017 Oct 10. doi: 10.1038/ajg.2017.
    >> Share

  275. REIG A, Sese P, Pares A
    Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.
    Am J Gastroenterol. 2017 Oct 10. doi: 10.1038/ajg.2017.
    >> Share

  276. PARIKH ND
    PRO: Hepatocellular Carcinoma Surveillance: A Useful Tool Against the Rising Tide of HCC.
    Am J Gastroenterol. 2017 Oct 3. doi: 10.1038/ajg.2017.
    >> Share

  277. KECK C, Shetty A, Mischen B, Willner I, et al
    Hepatic Splenosis Masquerading as Hepatocellular Carcinoma in a Chronic Hepatitis C Patient.
    Am J Gastroenterol. 2017;112:1493.
    >> Share

  278. PRICE JC, Tien PC
    Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?
    Am J Gastroenterol. 2017;112:1506-1507.
    >> Share

    September 2017
  279. UNGPRASERT P, Crowson CS, Simonetto DA, Matteson EL, et al
    Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.
    Am J Gastroenterol. 2017 Sep 5. doi: 10.1038/ajg.2017.
    >> Share

  280. ARGO CK, Caldwell SH
    Editorial: Severe Acute Liver Injury: Cause Connects to Outcome.
    Am J Gastroenterol. 2017;112:1397-1399.
    >> Share

  281. CHALASANI N, Reddy KRK, Fontana RJ, Barnhart H, et al
    Idiosyncratic Drug Induced Liver Injury in African-Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians.
    Am J Gastroenterol. 2017;112:1382-1388.
    >> Share

  282. KOCH DG, Speiser JL, Durkalski V, Fontana RJ, et al
    The Natural History of Severe Acute Liver Injury.
    Am J Gastroenterol. 2017;112:1389-1396.
    >> Share

    August 2017
  283. PIANO S, Morando F, Carretta G, Tonon M, et al
    Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    >> Share

  284. TSENG TC, Liu CJ, Su TH, Yang WT, et al
    Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    >> Share

  285. SCHAFFELLNER S, Stadlbauer V, Sereinigg M, Miller H, et al
    Niacin-Associated Acute Hepatotoxicity Leading to Emergency Liver Transplantation.
    Am J Gastroenterol. 2017;112:1345-1346.
    >> Share

  286. LUEDKE C, Ravindra K, Hertzberg B, Berg C, et al
    A Rapidly Enlarging Mullerian-Derived Hepatic Adenomyoma Clinically Mimicking Hepatic Adenoma in a Pregnant Woman.
    Am J Gastroenterol. 2017;112:1217.
    >> Share

  287. GEORGE NE, Raghavapuram S, Banerjee D, Al-Shoha M, et al
    Ectopic Hepatocellular Carcinoma within a Choledochal Cyst Diagnosed Using Single-Operator Digital Cholangioscopy.
    Am J Gastroenterol. 2017;112:1347-1348.
    >> Share

  288. BUGIANESI E, Bizzarri C, Rosso C, Mosca A, et al
    Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2017;112:1277-1286.
    >> Share

    June 2017
  289. KANWAL F, Tansel A, Kramer JR, Feng H, et al
    Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013.
    Am J Gastroenterol. 2017 Jun 13. doi: 10.1038/ajg.2017.
    >> Share

  290. KAMAL S, Khan MA, Seth A, Cholankeril G, et al
    Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2017 Jun 6. doi: 10.1038/ajg.2017.
    >> Share

  291. LIU J, Ghaziani TT, Wolf JL
    Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management.
    Am J Gastroenterol. 2017;112:838-846.
    >> Share

  292. PHAN F, Rowe K, Salyers WJ
    A Risky Relationship: The Splenic Artery and Walled-Off Pancreatic Necrosis.
    Am J Gastroenterol. 2017;112:834.
    >> Share

    May 2017
  293. KHAN SA, Pham C, Seah D, Ranatunga D, et al
    Acute Life-Threatening Portal Hypertension After Portosystemic Shunt Embolization.
    Am J Gastroenterol. 2017;112:816-818.
    >> Share

  294. LO GH
    Did Carvedilol Really Have More Severe Adverse Events than Propranolol in Cirrhotic Patients?
    Am J Gastroenterol. 2017;112:808.
    >> Share

  295. SARKAR M, Wellons M, Cedars MI, VanWagner L, et al
    Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
    Am J Gastroenterol. 2017;112:755-762.
    >> Share

  296. MCPHERSON S, Hardy T, Dufour JF, Petta S, et al
    Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.
    Am J Gastroenterol. 2017;112:740-751.
    >> Share

  297. STINE JG, Rinella ME
    Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?
    Am J Gastroenterol. 2017;112:752-754.
    >> Share

    April 2017
  298. WONG F, O'Leary JG, Reddy KR, Garcia-Tsao G, et al
    Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    >> Share

  299. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    >> Share

  300. CHEN SC, Chao Y, Yang MH
    Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report.
    Am J Gastroenterol. 2017;112:659-660.
    >> Share

    March 2017
  301. JOHN BV, Khalili K
    Editorial: Not All Nodules Are Created Equal: A Personalized Approach to Indeterminate (<2 cm) Nodules Identified on HCC Surveillance.
    Am J Gastroenterol. 2017;112:471-472.
    >> Share

    January 2017
  302. FELDMAN A, Eder SK, Felder TK, Kedenko L, et al
    Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
    Am J Gastroenterol. 2017;112:102-110.
    >> Share

  303. ARGO CK, Henry ZH
    Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI... Is It in the Genes?
    Am J Gastroenterol. 2017;112:111-113.
    >> Share

    October 2016
  304. FLOREANI A, Mangini C, Reig A, Franceschet I, et al
    Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers.
    Am J Gastroenterol. 2016 Oct 25. doi: 10.1038/ajg.2016.
    >> Share

    July 2016
  305. FLORES A, Asrani SK
    Editorial: Magnetic Resonance Elastography and Non-Alcoholic Fatty Liver Disease: Time for an Upgrade?
    Am J Gastroenterol. 2016;111:995-6.
    >> Share

    June 2016
  306. KISHORE R, Loomba R, Sterling RK
    Editorial: A New Spin on Magnetic Resonance Elastography.
    Am J Gastroenterol. 2016;111:834-7.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016